@article{2f750039fb4d47b3903bdecbc8285821,
title = "Future Aspects for Cannabinoids in Breast Cancer Therapy",
keywords = "Animals, Breast Neoplasms/drug therapy, Cannabinoids/chemistry, Estrogens/metabolism, Female, Humans, Receptors, Cannabinoid/metabolism, PLANT CANNABINOIDS, Cannabis sativa, delta-9-tetrahydrocannabinol, CBD, ANANDAMIDE, ENDOCANNABINOID SYSTEM, DELTA(9)-TETRAHYDROCANNABINOL, breast cancer, cannabinoid receptor, ESTROGEN-RECEPTOR BETA, THC, cannabidiol, MOLECULAR TARGETS, CB1, INHIBITION, CANNABIDIOLIC ACID, TUMOR-GROWTH, Cannabidiol, Cannabinoid receptor, Delta-9-tetrahydrocannabinol, Breast cancer",
author = "Ter{\'e}zia Kiskov{\'a} and Felicitas Mungenast and M{\'a}ria Suv{\'a}kov{\'a} and Walter J{\"a}ger and Theresia Thalhammer",
note = "Publisher Copyright: {\textcopyright} 2019 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2019",
month = apr,
day = "3",
doi = "10.3390/ijms20071673",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1422-0067",
publisher = "MDPI AG",
number = "7",
}